Literature DB >> 17532262

Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.

Jochem Hogenhuis1, Adriaan A Voors, Tiny Jaarsma, Arno W Hoes, Hans L Hillege, Johannes A Kragten, Dirk J van Veldhuisen.   

Abstract

BACKGROUND: Anaemia may affect B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels, but this has not been well described in heart failure (HF) patients without the exclusion of patients with renal dysfunction. AIMS: To study the influence of both anaemia and renal function on BNP and NT-proBNP levels in a large group of hospitalised HF patients. METHODS AND
RESULTS: We studied 541 patients hospitalised for HF (mean age 71+/-11 years, 62% male, and left ventricular ejection fraction 0.33+/-0.14). Of these patients, 30% (n=159) were anaemic (women: Hb<7.5 mmol/l, men: Hb<8.1 mmol/l). Of the 159 anaemic patients, 73% had renal dysfunction (eGFR<60 ml/min/1.73 m2) and of the non-anaemic patients, 57% had renal dysfunction. BNP and NT-proBNP levels were measured in all patients before discharge. In multivariable analyses both plasma haemoglobin and eGFR were independently related to the levels of BNP and NT-proBNP (standardised beta's of -0.16, -0.14 [BNP] and -0.19, -0.26 [NT-proBNP] respectively, P-values<0.01).
CONCLUSION: Anaemia and renal dysfunction are related to increased BNP and NT-proBNP levels, independent of the severity of HF. These results indicate that both anaemia and renal dysfunction should be taken into consideration during the interpretation of BNP and NT-proBNP levels in HF patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532262     DOI: 10.1016/j.ejheart.2007.04.001

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  21 in total

1.  Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio.

Authors:  Juliana Jensen; Li-Ping Ma; Michael L X Fu; David Svaninger; Per-Arne Lundberg; Ola Hammarsten
Journal:  Clin Res Cardiol       Date:  2010-03-13       Impact factor: 5.460

2.  Galectin 3 complements BNP in risk stratification in acute heart failure.

Authors:  Gregory J Fermann; Christopher J Lindsell; Alan B Storrow; Kimberly Hart; Matthew Sperling; Susan Roll; Neal L Weintraub; Karen F Miller; David J Maron; Allen J Naftilan; John A McPherson; Douglas B Sawyer; Robert Christenson; Sean P Collins
Journal:  Biomarkers       Date:  2012-09-24       Impact factor: 2.658

Review 3.  Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.

Authors:  Dirk J van Veldhuisen; Stefan D Anker; Piotr Ponikowski; Iain C Macdougall
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

4.  Correlates of NT-proBNP concentration in patients with essential hypertension in absence of congestive heart failure.

Authors:  Keizo Toda; Yukihito Sato; Tomoko Hara; Kenro Hijiya; Ryutaro Kaneko; Tatuo Okada; Yoshiki Takatsu; Hisayoshi Fujiwara; Toshiaki Iwasaki
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 5.  Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity.

Authors:  Lars Michel; Tienush Rassaf; Matthias Totzeck
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

6.  Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.

Authors:  S Yi; G Contreras; E R Miller; L J Appel; B C Astor
Journal:  Am J Nephrol       Date:  2008-09-29       Impact factor: 3.754

7.  Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.

Authors:  Dirk J A Lok; Peter Van Der Meer; Pieta W Bruggink-André de la Porte; Erik Lipsic; Jan Van Wijngaarden; Hans L Hillege; Dirk J van Veldhuisen
Journal:  Clin Res Cardiol       Date:  2010-02-04       Impact factor: 5.460

Review 8.  Anemia and the potential role of erythropoiesis-stimulating agents in heart failure.

Authors:  Haroon A Faraz; Syed F Zafar; Jalal K Ghali
Journal:  Curr Heart Fail Rep       Date:  2008-06

9.  Anemia is independently associated with NT-proBNP levels in asymptomatic predialysis patients with chronic kidney disease.

Authors:  B Tirmenstajn-Jankovic; N Dimkovic; G Perunicic-Pekovic; Z Radojicic; D Bastac; S Zikic; M Zivanovic
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

10.  Usefulness of amino terminal pro-B-type natriuretic peptide in evaluating children with cardiac failure.

Authors:  Isoken A Isah; Wilson E Sadoh; Nosakhare J Iduoriyekemwen
Journal:  Cardiovasc Diagn Ther       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.